Effect of Multielectrode Versus Point-by-Point Mapping on Recurrence of Ventricular Tachycardia in Ischemic Heart Disease
A trial with no phase registered on ClinicalTrials.gov. The registry status is suspended. It plans to enroll 180 participants.
Also called NCT05203484
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 180 participants
- Sponsor
- Registry
-
NCT05203484
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Germany
- Registry status
- Suspended
Technical summary
Registry record NCT05203484. Randomized; no masking; primary purpose treatment. Start 2022-10-01 (anticipated); primary completion 2023-07-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Effect of Multielectrode Versus Point-by-Point Mapping on Recurrence of Ventricular Tachycardia in Ischemic Heart Disease
- Acronym
- EMPIRE-VT
- Condition
- Ventricular Tachycardia
- Intervention (Device)
- Multielecotrde Mapping
- Intervention (Device)
- Point-by-point mapping
- Lead sponsor
- Helios Health Institute GmbH
Record details
- Record id
cardio:ct-nct05203484- Content hash
44b724cee897a9a4085acf53fd083c6c8dee81a669b2733c9788fca3f103e4b0